blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3104864

EP3104864 - METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.01.2019
Database last updated on 30.10.2024
FormerRequest for examination was made
Status updated on  18.11.2016
Most recent event   Tooltip11.01.2019Application deemed to be withdrawnpublished on 13.02.2019  [2019/07]
Applicant(s)For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75013 Paris / FR
For all designated states
Institut Pasteur De Lille
1 rue du Professeur Calmette
59000 Lille / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Université de Lille 1 Sciences et Technologies
Cité Scientifique
59650 Villeneuve d'Ascq / FR
For all designated states
Université de Droit et de la Santé de Lille 2
42, rue Paul Duez
59800 Lille / FR
[2016/51]
Inventor(s)01 / GOSSET, Philippe
Inserm U 1019
Institut Pasteur de Lille
1 Rue du Professeur Calmette
BP245
F-59019 Lille Cedex / FR
02 / PICHAVANT, Muriel
Inserm U 1019
Institut Pasteur de Lille
1 Rue du Professeur Calmette
BP245
F-59019 Lille Cedex / FR
03 / REMY, Gaëlle
Inserm U 1019
Institut Pasteur de Lille
1 Rue du Professeur Calmette
BP245
F-59019 Lille Cedex / FR
 [2016/51]
Representative(s)Collin, Matthieu
Inserm-Transfert
Paris Biopark
7, rue Watt
75013 Paris / FR
[2016/51]
Application number, filing date15705274.713.02.2015
[2016/51]
WO2015EP53041
Priority number, dateEP2014030520114.02.2014         Original published format: EP 14305201
[2016/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015121393
Date:20.08.2015
Language:EN
[2015/33]
Type: A1 Application with search report 
No.:EP3104864
Date:21.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 20.08.2015 takes the place of the publication of the European patent application.
[2016/51]
Search report(s)International search report - published on:EP20.08.2015
ClassificationIPC:A61K31/7032, C07K16/28, A61K39/00
[2016/51]
CPC:
A61K31/7032 (EP,US); A61K39/092 (US); A61K39/102 (US);
A61K45/06 (US); C07K16/2809 (EP,US); A61K2039/505 (EP,US);
C07K2317/52 (US); C07K2317/75 (US); Y02A50/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/51]
TitleGerman:VERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG AKUTER VERSCHLIMMERUNGEN DER CHRONISCH OBSTRUKTIVEN LUNGENERKRANKUNG[2016/51]
English:METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE[2016/51]
French:PROCÉDÉS ET COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT D'EXACERBATIONS AIGUËS DE LA MALADIE PULMONAIRE OBSTRUCTIVE CHRONIQUE[2016/51]
Entry into regional phase06.07.2016National basic fee paid 
06.07.2016Designation fee(s) paid 
06.07.2016Examination fee paid 
Examination procedure06.07.2016Amendment by applicant (claims and/or description)
06.07.2016Examination requested  [2016/51]
06.07.2016Date on which the examining division has become responsible
01.09.2018Application deemed to be withdrawn, date of legal effect  [2019/07]
04.10.2018Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2019/07]
Fees paidRenewal fee
23.02.2017Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
28.02.201804   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2011149881  (CHILDRENS MEDICAL CENTER [US], et al) [X] 1 * claims 19, 20 * * page 31, paragraph 110 * * page 75, paragraph 263 * * page 22, paragraph 64; figures 7A-7G * [I] 1-18;
 [XDI]WO2013063395  (NKT THERAPEUTICS INC [US]) [XD] 1,6 * claims 1, 2, 7, 38; sequences 28, 29 * [I] 1,6-14;
 [I]  - SHIRONJIT SAHA ET AL, "Eosinophilic airway inflammation in COPD", INTERNATIONAL JOURNAL OF COPD, (20060101), vol. 1, pages 39 - 47, XP055113673 [I] 1-18 * the whole document *
 [Y]  - KAWAKAMI KAZUYOSHI ET AL, "Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, (20031201), vol. 33, no. 12, doi:10.1002/EJI.200324254, ISSN 0014-2980, pages 3322 - 3330, XP002455359 [Y] 1-18 * abstract *

DOI:   http://dx.doi.org/10.1002/eji.200324254
 [Y]  - YUKO MORISHIMA ET AL, "Suppression of eosinophilic airway inflammation by treatment with [alpha]-galactosylceramide", EUROPEAN JOURNAL OF IMMUNOLOGY, (20051001), vol. 35, no. 10, doi:10.1002/eji.200525994, ISSN 0014-2980, pages 2803 - 2814, XP055111416 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1002/eji.200525994
 [A]  - DAVID DOMBROWICZ, "Exploiting the innate immune system to control allergic asthma", EUROPEAN JOURNAL OF IMMUNOLOGY, (20051001), vol. 35, no. 10, doi:10.1002/eji.200535425, ISSN 0014-2980, pages 2786 - 2788, XP055111415 [A] 1-18

DOI:   http://dx.doi.org/10.1002/eji.200535425
 [A]  - Patricia Hachem ET AL, "Frontline: a-Galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: Role of IFN-c", (20051001), URL: http://onlinelibrary.wiley.com/store/10.1002/eji.200535268/asset/2793_ftp.pdf?v=1&t=hp0vseqw&s=36da291c1be3959fec09595bbfc51c3d22bb1e77, (20131210), XP055092438 [A] 1-18 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.